Last reviewed · How we verify
Tozinameran 12 Years of age and older (tozinameran-12-years-of-age-and-older)
Tozinameran 12 Years of age and older (generic name: tozinameran-12-years-of-age-and-older) is a vaccine drug developed by Pfizer. It is currently FDA-approved for Prevention of COVID-19 in individuals 12 years of age and older.
Tozinameran, developed by Pfizer Inc., is a COVID-19 vaccine for individuals 12 years of age and older. It works by stimulating the body's immune system to produce antibodies against the SARS-CoV-2 virus. The key indication is the prevention of COVID-19. Tozinameran has clinical differentiation due to its effectiveness in preventing severe illness and hospitalization. It has significant commercial value, generating $21.2B in revenue. There are no notable pipeline developments for this drug.
At a glance
| Generic name | tozinameran-12-years-of-age-and-older |
|---|---|
| Sponsor | Pfizer |
| Drug class | vaccine |
| Target | SARS-CoV-2 spike protein |
| Therapeutic area | Immunology |
| Phase | FDA-approved |
Approved indications
- Prevention of COVID-19 in individuals 12 years of age and older
Common side effects
Drug interactions
- Live, intranasal influenza vaccines
- Live vaccines
- Other vaccines
- Thrombolytic agents
- Warfarin
- Anticoagulants
- Antiplatelet agents
- Immunosuppressives
- Live, oral influenza vaccines
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tozinameran 12 Years of age and older CI brief — competitive landscape report
- Tozinameran 12 Years of age and older updates RSS · CI watch RSS
- Pfizer portfolio CI
Frequently asked questions about Tozinameran 12 Years of age and older
What is Tozinameran 12 Years of age and older?
What is Tozinameran 12 Years of age and older used for?
Who makes Tozinameran 12 Years of age and older?
What is the generic name of Tozinameran 12 Years of age and older?
What drug class is Tozinameran 12 Years of age and older in?
What development phase is Tozinameran 12 Years of age and older in?
What does Tozinameran 12 Years of age and older target?
Related
- Drug class: All vaccine drugs
- Target: All drugs targeting SARS-CoV-2 spike protein
- Manufacturer: Pfizer — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Prevention of COVID-19 in individuals 12 years of age and older
- Compare: Tozinameran 12 Years of age and older vs similar drugs
- Pricing: Tozinameran 12 Years of age and older cost, discount & access